The Cooper Companies, Inc. 

(Public, NYSE:COO)   Watch this stock   
Find more results for COO
Dec 8, 2009
Q4 2009 Earnings Conference Call - 5:00PM EST - Add to calendar
Dec 8, 2009
Q4 2009 Earnings Release - 4:00PM EST - Add to calendar
Sep 10, 2009
Robert W. Baird & Co., Inc. Health Care Conference
Sep 9, 2009
Thomas Weisel Partners Healthcare Conference
Sep 3, 2009
Q3 2009 Earnings Conference Call - Webcast
Sep 3, 2009
Q3 2009 Earnings Release
More events from AOL Finance »    

Key stats and ratios

Q3 (Jul '09) 2008
Net profit margin 7.68% 6.16%
Operating margin 11.89% 11.94%
EBITD margin - 19.67%
Return on average assets 3.43% 2.53%
Return on average equity 5.97% 4.55%
Employees 7,400 -

Address

6140 Stoneridge Mall Road Suite 590
Pleasanton, CA 94588
United States - Map
+1-925-4603600 (Phone)
+1-925-4603649 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Options - Morningstar
Research Reports - Yahoo Finance
Annual Report (PDF) - AnnualReports.com

The Cooper Companies, Inc. discussed on blogs

The Cooper Companies, Inc. discussions

  View all discussions »

Description

The Cooper Companies, Inc. (Cooper) develops, manufactures and markets healthcare products, primarily medical devices, through its two business units: CooperVision, Inc. (CVI) and CooperSurgical, Inc. (CSI). CVI develops, manufactures and markets a range of contact lenses for the worldwide vision correction market. CSI develops, manufactures and markets medical devices, diagnostic products, and surgical instruments and accessories used primarily by gynecologists and obstetricians. On February 22, 2007, CSI acquired Wallach Surgical Devices, Inc. Wallach’s products consist of various diagnostic and therapeutic medical instruments primarily for in-office use in women’s healthcare and other specialty instruments relating to dermatology, ophthalmology, anesthesiology, dentistry and veterinary medicine.

Officers and directors

A. Thomas Bender
Chairman of the Board
Age: 70
Bio & Compensation - Reuters
Robert S. Weiss
Chief Executive Officer, President, Director
Age: 62
Bio & Compensation - Reuters
Allan E. Rubenstein M.D.
Vice Chairman of the Board, Lead Director
Age: 64
Bio & Compensation - Reuters
Eugene J. Midlock
Chief Financial Officer, Senior Vice President
Age: 64
Bio & Compensation - Reuters
Nicholas J. Pichotta
Chief Executive Officer of CooperSurgical, Inc.
Age: 64
Bio & Compensation - Reuters
Paul L. Remmell
President, Chief Operating Officer of CooperSurgical, Inc.
Age: 51
Bio & Compensation - Reuters
John Arthur Weber
President - CooperVision, Inc.
Age: 44
Bio & Compensation - Reuters
Andrew Sedgwick
President, EMEA of CooperVision, Inc.
Age: 43
Bio & Compensation - Reuters
Dennis J. Murphy
President, Americas of CooperVision, Inc.
Age: 50
Bio & Compensation - Reuters
Carol R. Kaufman
Senior Vice President - Legal Affairs, Secretary, Chief Administrative Officer
Age: 60
Bio & Compensation - Reuters